CYCN
Cyclerion Therapeutics, Inc. · Healthcare
Slate Path Capital LP sold $555K of Cyclerion Therapeutics, Inc.
10% owner
Sold$555,108
$1.55Price
357,880Shares
−100%Stake
What CYCN did after the filing
- The stock from Mon, Nov 25 close, $1.45
- +126.9%
- S&P 500, same days
- −2.5%
Measured over 30 trading days, to the Jan 10 close.
Traded Thu, Nov 21. Filed Mon, Nov 25, 11:05 AM ET, during the session. Returns use the Nov 25 close and the Jan 10 close. Not investment advice.